跳至主要内容
临床试验/NCT01075867
NCT01075867已完成不适用

Multi-dimensional Prevention Program After Acute Coronary Syndrome (ELIPS) (SPUM-ACS- SP1)

University Hospital, Geneva3 个研究点 分布在 1 个国家目标入组 2,498 人开始时间: 2010年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
2,498
试验地点
3
主要终点
composite of death and cardiovascular event

研究概览

简要总结

To demonstrate the effectiveness of the ELIPS programme (Multi-dimEnsionaL preventIon Program after Acute coronary Syndrome), which aims at improving quality of care of patients admitted to hospital with Acute Coronary Syndrome (ACS) in the Swiss setting. The program targets an increase in prescription rates by physicians and long term medication adherence and adoption of healthy lifestyle attitudes by patients.

The program is dedicated to caregivers to increase their application of guidelines into practice, to increase their confidence in therapeutic education of patients, and to patients to improve their understanding of ACS and its treatment and to increase their motivation for long term treatment,.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients >18 years
  • Admitted for an ACS, that is with symptoms compatible with angina pectoris (chest pain, breathlessness) and at least one of the following 3 features : a) Elevation or depression of the ST segment, inverted T waves or dynamic changes in the repolarization phase b) Positive troponin c) Known coronary artery disease. A significant coronary artery disease must be confirmed angiographically.

排除标准

  • Severe physical disability or dement
  • Less than 1 year of life expectancy for non cardiac reason

结局指标

主要结局

composite of death and cardiovascular event

时间窗: 1 year

Composite of * death from any cause, * myocardial infarction, * documented unstable angina requiring rehospitalization, * revascularization (performed at least 30 days after randomization), * documented new or worsen lower limb ischemia, * stroke * transient cerebral ischemic accident.

次要结局

  • Clinical outcomes at follow-up(1 year)
  • Process outcome at discharge(1 year)
  • Surrogate outcomes at follow-up(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

François MACH

Pr

University of Bern

研究点 (3)

Loading locations...

相似试验

Multi-dimensional Prevention Program After Acute... | 临床试验